Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $PFE vs $VTRS | Chartloom

Compare

$PFE vs $VTRS

Pfizer Inc · Viatris Inc

PFE

Pfizer Inc

VTRS

Viatris Inc

Compare $PFE vs $VTRS

Comparing Pfizer Inc and Viatris Inc

PFEPfizer Inc

VTRSViatris Inc

PFEPfizer Inc

Market cap

$161.69B

P/E (TTM)

37.32x

Forward P/E (NTM)

10.22x

Forward P/S (NTM)

2.63x

Rev growth (TTM)

-0.2%

YTD performance

12.7%

52W performance

14.5%

FCF yield

6.8%

VTRSViatris Inc

Market cap

$20.09B

P/E (TTM)

—

Forward P/E (NTM)

6.60x

Forward P/S (NTM)

1.33x

Rev growth (TTM)

4.4%

YTD performance

38.4%

52W performance

77.1%

FCF yield

9.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PFE

VTRS

Detailed metrics comparison

PFE

Pfizer Inc

VTRS

Viatris Inc

Market Cap

PFE$161.69B

VTRS$20.09B

Enterprise Value

PFE$223.91B

VTRS$32.55B

Price

PFE$28.37

VTRS$17.25

P/E Ratio

PFE37.32x

VTRSN/A

P/S Ratio

PFE2.54x

VTRS1.36x

EV/Sales

PFE3.52x

VTRS2.21x

EV/EBITDA

PFE7.96x

VTRS8.00x

P/B Ratio

PFE1.89x

VTRS1.42x

P/FCF Ratio

PFE14.72x

VTRS11.09x

EV/FCF

PFE20.38x

VTRS17.96x

PEG Ratio

PFEN/A

VTRSN/A

Forward P/E (NTM)

PFE10.22x

VTRS6.60x

Forward P/S (NTM)

PFE2.63x

VTRS1.33x

Revenue (TTM)

PFE$63.70B

VTRS$14.74B

Revenue Growth (YoY)

PFE-0.2%

VTRS4.4%

Forward Rev Growth

PFE-3.8%

VTRS2.0%

Gross Margin (TTM)

PFE74.7%

VTRS40.3%

Operating Margin (TTM)

PFE6.8%

VTRS0.0%

EBITDA Margin (TTM)

PFE41.7%

VTRS27.2%

Net Margin (TTM)

PFE6.8%

VTRS-2.8%

FCF Margin (TTM)

PFE17.2%

VTRS12.3%

Net Income (TTM)

PFE$4.33B

VTRS$-411M

FCF (TTM)

PFE$10.99B

VTRS$1.81B

EPS (TTM)

PFE$0.76

VTRS-$0.35

ROE (TTM)

PFE4.9%

VTRS-279.0%

ROA (TTM)

PFE2.1%

VTRS-112.0%

ROIC (TTM)

PFE2.9%

VTRS-142.0%

Cash

PFE$976M

VTRS$887M

Debt

PFE$63.19B

VTRS$13.35B

Net Cash/Debt

PFE$-62.22B

VTRS$-12.46B

Current Ratio (TTM)

PFE1.27x

VTRS1.58x

Quick Ratio (TTM)

PFE0.96x

VTRS0.83x

Debt/Equity (TTM)

PFE0.74x

VTRS0.94x

Debt/Assets (TTM)

PFE0.0%

VTRS0.0%

Interest Coverage (TTM)

PFEN/A

VTRSN/A

Net Debt/EBITDA (TTM)

PFE0.00x

VTRS0.00x

Beta

PFE0.31

VTRS0.89

52W Performance

PFE14.5%

VTRS77.1%

YTD Performance

PFE12.7%

VTRS38.4%

% from 52W High

PFE-2.9%

VTRS-6.4%

% from 52W Low

PFE20.1%

VTRS77.3%

Asset Turnover (TTM)

PFE0.31x

VTRS0.40x

FCF Yield (TTM)

PFE6.8%

VTRS9.0%

Earnings Yield (TTM)

PFE2.7%

VTRS-2.0%

Dividend Yield (TTM)

PFE6.1%

VTRS2.7%

Rule of 40

PFE17.0

VTRS16.7

EV/GP/RG

PFEN/A

VTRS1.97

Ticker research

View PFE research View VTRS research

Metric	PFE Pfizer Inc	VTRS Viatris Inc
Market & Valuation
Market Cap	$161.69B	$20.09B
Enterprise Value	$223.91B	$32.55B
Price	$28.37	$17.25
P/E Ratio	37.32x	N/A
P/S Ratio	2.54x	1.36x
EV/Sales	3.52x	2.21x
EV/EBITDA	7.96x	8.00x
P/B Ratio	1.89x	1.42x
P/FCF Ratio	14.72x	11.09x
EV/FCF	20.38x	17.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	10.22x	6.60x
Forward P/S (NTM)	2.63x	1.33x
Revenue & Growth
Revenue (TTM)	$63.70B	$14.74B
Revenue Growth (YoY)	-0.2%	4.4%
Forward Rev Growth	-3.8%	2.0%
Profitability
Gross Margin (TTM)	74.7%	40.3%
Operating Margin (TTM)	6.8%	0.0%
EBITDA Margin (TTM)	41.7%	27.2%
Net Margin (TTM)	6.8%	-2.8%
FCF Margin (TTM)	17.2%	12.3%
Net Income (TTM)	$4.33B	$-411M
FCF (TTM)	$10.99B	$1.81B
EPS (TTM)	$0.76	-$0.35
ROE (TTM)	4.9%	-279.0%
ROA (TTM)	2.1%	-112.0%
ROIC (TTM)	2.9%	-142.0%
Financial Health
Cash	$976M	$887M
Debt	$63.19B	$13.35B
Net Cash/Debt	$-62.22B	$-12.46B
Current Ratio (TTM)	1.27x	1.58x
Quick Ratio (TTM)	0.96x	0.83x
Debt/Equity (TTM)	0.74x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	0.89
52W Performance	14.5%	77.1%
YTD Performance	12.7%	38.4%
% from 52W High	-2.9%	-6.4%
% from 52W Low	20.1%	77.3%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.40x
FCF Yield (TTM)	6.8%	9.0%
Earnings Yield (TTM)	2.7%	-2.0%
Dividend Yield (TTM)	6.1%	2.7%
Other
Rule of 40	17.0	16.7
EV/GP/RG	N/A	1.97
Ticker research	View PFE research	View VTRS research

Valuation

P/E Ratio

PFE

37.32x

P/S Ratio

VTRS

1.36x

PFE

2.54x

EV/FCF

VTRS

17.96x

PFE

20.38x

Growth & revenue

Revenue Growth TTM

VTRS

4.4%

PFE

-0.2%

Forward Revenue Growth

VTRS

2.0%

PFE

-3.8%

Profitability & performance

Gross Margin

PFE

74.7%

VTRS

40.3%

ROE

PFE

4.9%

VTRS

-279.0%

FCF Yield %

VTRS

9.0%

PFE

6.8%

52-Week Performance

VTRS

77.1%

PFE

14.5%

Detailed metrics comparison

PFE

Pfizer Inc

VTRS

Viatris Inc

Market Cap

PFE$161.69B

VTRS$20.09B

Enterprise Value

PFE$223.91B

VTRS$32.55B

Price

PFE$28.37

VTRS$17.25

P/E Ratio

PFE37.32x

VTRSN/A

P/S Ratio

PFE2.54x

VTRS1.36x

EV/Sales

PFE3.52x

VTRS2.21x

EV/EBITDA

PFE7.96x

VTRS8.00x

P/B Ratio

PFE1.89x

VTRS1.42x

P/FCF Ratio

PFE14.72x

VTRS11.09x

EV/FCF

PFE20.38x

VTRS17.96x

PEG Ratio

PFEN/A

VTRSN/A

Forward P/E (NTM)

PFE10.22x

VTRS6.60x

Forward P/S (NTM)

PFE2.63x

VTRS1.33x

Revenue (TTM)

PFE$63.70B

VTRS$14.74B

Revenue Growth (YoY)

PFE-0.2%

VTRS4.4%

Forward Rev Growth

PFE-3.8%

VTRS2.0%

Gross Margin (TTM)

PFE74.7%

VTRS40.3%

Operating Margin (TTM)

PFE6.8%

VTRS0.0%

EBITDA Margin (TTM)

PFE41.7%

VTRS27.2%

Net Margin (TTM)

PFE6.8%

VTRS-2.8%

FCF Margin (TTM)

PFE17.2%

VTRS12.3%

Net Income (TTM)

PFE$4.33B

VTRS$-411M

FCF (TTM)

PFE$10.99B

VTRS$1.81B

EPS (TTM)

PFE$0.76

VTRS-$0.35

ROE (TTM)

PFE4.9%

VTRS-279.0%

ROA (TTM)

PFE2.1%

VTRS-112.0%

ROIC (TTM)

PFE2.9%

VTRS-142.0%

Cash

PFE$976M

VTRS$887M

Debt

PFE$63.19B

VTRS$13.35B

Net Cash/Debt

PFE$-62.22B

VTRS$-12.46B

Current Ratio (TTM)

PFE1.27x

VTRS1.58x

Quick Ratio (TTM)

PFE0.96x

VTRS0.83x

Debt/Equity (TTM)

PFE0.74x

VTRS0.94x

Debt/Assets (TTM)

PFE0.0%

VTRS0.0%

Interest Coverage (TTM)

PFEN/A

VTRSN/A

Net Debt/EBITDA (TTM)

PFE0.00x

VTRS0.00x

Beta

PFE0.31

VTRS0.89

52W Performance

PFE14.5%

VTRS77.1%

YTD Performance

PFE12.7%

VTRS38.4%

% from 52W High

PFE-2.9%

VTRS-6.4%

% from 52W Low

PFE20.1%

VTRS77.3%

Asset Turnover (TTM)

PFE0.31x

VTRS0.40x

FCF Yield (TTM)

PFE6.8%

VTRS9.0%

Earnings Yield (TTM)

PFE2.7%

VTRS-2.0%

Dividend Yield (TTM)

PFE6.1%

VTRS2.7%

Rule of 40

PFE17.0

VTRS16.7

EV/GP/RG

PFEN/A

VTRS1.97

Ticker research

View PFE research View VTRS research

Metric	PFE Pfizer Inc	VTRS Viatris Inc
Market & Valuation
Market Cap	$161.69B	$20.09B
Enterprise Value	$223.91B	$32.55B
Price	$28.37	$17.25
P/E Ratio	37.32x	N/A
P/S Ratio	2.54x	1.36x
EV/Sales	3.52x	2.21x
EV/EBITDA	7.96x	8.00x
P/B Ratio	1.89x	1.42x
P/FCF Ratio	14.72x	11.09x
EV/FCF	20.38x	17.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	10.22x	6.60x
Forward P/S (NTM)	2.63x	1.33x
Revenue & Growth
Revenue (TTM)	$63.70B	$14.74B
Revenue Growth (YoY)	-0.2%	4.4%
Forward Rev Growth	-3.8%	2.0%
Profitability
Gross Margin (TTM)	74.7%	40.3%
Operating Margin (TTM)	6.8%	0.0%
EBITDA Margin (TTM)	41.7%	27.2%
Net Margin (TTM)	6.8%	-2.8%
FCF Margin (TTM)	17.2%	12.3%
Net Income (TTM)	$4.33B	$-411M
FCF (TTM)	$10.99B	$1.81B
EPS (TTM)	$0.76	-$0.35
ROE (TTM)	4.9%	-279.0%
ROA (TTM)	2.1%	-112.0%
ROIC (TTM)	2.9%	-142.0%
Financial Health
Cash	$976M	$887M
Debt	$63.19B	$13.35B
Net Cash/Debt	$-62.22B	$-12.46B
Current Ratio (TTM)	1.27x	1.58x
Quick Ratio (TTM)	0.96x	0.83x
Debt/Equity (TTM)	0.74x	0.94x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	0.89
52W Performance	14.5%	77.1%
YTD Performance	12.7%	38.4%
% from 52W High	-2.9%	-6.4%
% from 52W Low	20.1%	77.3%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.40x
FCF Yield (TTM)	6.8%	9.0%
Earnings Yield (TTM)	2.7%	-2.0%
Dividend Yield (TTM)	6.1%	2.7%
Other
Rule of 40	17.0	16.7
EV/GP/RG	N/A	1.97
Ticker research	View PFE research	View VTRS research